Indegene reactivated inactive HCPs for a global pharma company's mature oncology drug treating metastatic breast cancer, growing revenue post-acquisition. Challenges involved maximizing prescriptions across the HCP universe, re-engaging existing/previous writers, and leveraging brand equity for compelling content to boost recall. Indegene's software segmented HCPs by Rx potential and digital affinity to identify 13,300 whitespace targets in NET indications, then established a marketing/sales operations hub to plan and execute targeted campaigns, driving engagement and revenue growth.

Join for free to read